Novartis Humira biosimilar''s high concentration dosage gets FDA review (NYSE:NVS)
Novartis (NVS) said the U.S. Food and Drug Administration ((FDA)) accepted an application for a high concentration formulation of 100 mg|mL ((HCF)) of Hyrimoz, a biosimilar…
Novartis Humira biosimilar''s high concentration dosage gets FDA review (NYSE:NVS)
Novartis (NVS) said the U.S. Food and Drug Administration ((FDA)) accepted an application for a high concentration formulation of 100 mg|mL ((HCF)) of Hyrimoz, a biosimilar…